Speaker illustration

Doctor Gentian Denas

University of Padua, Padova (Italy)

Member of:

European Society of Cardiology

Outcomes with oral anticoagulation resumption or discontinuation after an anticoagulation-related event in patients with atrial fibrillation

Event: ESC Congress 2023

Topic: Anticoagulants

Session: Oral anticoagulation: minimising bleeding

Thumbnail

Non-vitamin K antagonist oral anticoagulants in complex clinical scenarios: from validation of cardiometabolic risk scores to use in the frail elderly patient

Event: ESC Congress 2023

Topic: Oral Anticoagulant Drugs

Session: Non-vitamin K antagonist oral anticoagulants in complex clinical scenarios: from validation of cardiometabolic risk scores to use in the frail elderly patient

Thumbnail

Frailty and outcomes in octogenarians with atrial fibrillation treated with edoxaban: ESCAPE study

Event: ESC Congress 2022

Topic: Anticoagulants

Session: Challenges in cardiovascular pharmacotherapy in patients who are older or with comorbidities

Thumbnail

Incidence of atrial fibrillation in an opportunistic screening campaign in a general practitioner setting: a prospective population study

Event: ESC Congress 2020

Topic: Prevalence and Incidence of Atrial Fibrillation

Session: Atrial Fibrillation ePosters

Thumbnail

Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis

Event: ESC Congress 2019

Topic: Right Heart Catheterisation

Session: Interventional Cardiology

Thumbnail

Real world persistence with direct oral anticoagulants in anticoagulation naive patients with atrial fibrillation

Event: ESC Congress 2019

Topic: Anticoagulants

Session: Perspectives on anticoagulation across cardiovascular disease

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb